The Combination of MLN2238 (Ixazomib) With Interferon-Alpha Results in Enhanced Cell Death in Melanoma
Oncotarget - United States
doi 10.18632/oncotarget.12791
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 21, 2016
Authors
Publisher
Impact Journals, LLC